Skip to main content
Caplight Logo









PamGene International BV

PamGene International BV

Private
's-HertogenboschHealthcare & Life Scienceshttps://pamdx.com/

Last Round

Series A

Apr 16, 2026

Total Funding Raised

$23.5M

Company Overview

PamGene International BV is a biotechnology company that provides a peptide-based microarray technology for kinase activity profiling to support drug development and diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

kinase activity profilingfunctional proteomicsbiomarker discoveryin-vitro diagnosticsIVDmicroarray technologypatient stratificationdrug development toolscontract research organizationCROimmuno-oncologypersonalized medicinecellular signalingproteomics platform3D microarrayIOpener test

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PamGene International BV Comparables

Compare PamGene International BV with similar companies based on industry and business-model similarity.

PamGene International BV comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pepscope
81%
RayBiotech
79%
Biosynth
79%

PamGene International BV Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 16, 2026
GrantJun 27, 2023

PamGene International BV Investors

Notable investors and investment history

PamGene International BV investors
InvestorRounds
European Innovation Council FundGrant
Myosotis InvestmentsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 15, 2025

    Grew 16% QoQ, from 37 to 43 employees.

  • Jun 27, 2023

    Secured $8.2M from the European Innovation Council Fund.

PamGene International BV Filings

Explore SEC and related filing metadata, where available.

PamGene International BV filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PamGene International BV's valuation, stock price, and market status.

Is PamGene International BV a public or private company?

PamGene International BV is a private company.

What is the current stock price of PamGene International BV?

PamGene International BV is a private company with no public stock price. No recent secondary market data is available.

How much is PamGene International BV worth (valuation)?

Valuation information for PamGene International BV is not publicly available.

Can I buy PamGene International BV stock?

PamGene International BV shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PamGene International BV's last funding round?

Funding round information for PamGene International BV is not publicly available.

Who are the main investors in PamGene International BV?

Investor information for PamGene International BV is not publicly disclosed.

Will PamGene International BV IPO soon?

No public IPO plans have been announced for PamGene International BV.

How can I track PamGene International BV secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PamGene International BV's secondary market activity and sign up for updates.

Firmographic Details

Headquarters's-Hertogenbosch
Employee Range32
Year Founded1999
Last FundingApr 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?